SBC Medical Group (SBC) Projected to Announce Quarterly Earnings on Friday

SBC Medical Group (NASDAQ:SBC) is expected to announce its Q3 2026 results before the market opens on Friday, November 13th. Analysts expect SBC Medical Group to post earnings of $0.11 per share and revenue of $48.90 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Friday, November 13, 2026 at 8:30 AM ET.

SBC Medical Group (NASDAQ:SBC) last posted its quarterly earnings results on Thursday, August 13th. The company reported $0.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.02). The business had revenue of $49.19 million for the quarter, compared to analysts’ expectations of $45.37 million. SBC Medical Group had a return on equity of 18.47% and a net margin of 27.99%. On average, analysts expect SBC Medical Group to post $0.44 EPS for the current fiscal year and $0.52 EPS for the next fiscal year.

SBC Medical Group Trading Down 0.9%

NASDAQ SBC opened at $5.24 on Thursday. SBC Medical Group has a 1 year low of $2.78 and a 1 year high of $5.79. The company has a debt-to-equity ratio of 0.09, a current ratio of 3.31 and a quick ratio of 3.27. The company has a market capitalization of $538.92 million, a PE ratio of 11.15, a P/E/G ratio of 2.38 and a beta of 0.52. The company has a fifty day moving average of $5.04 and a 200 day moving average of $3.95.

Wall Street Analysts Forecast Growth

SBC has been the subject of several analyst reports. BTIG Research reissued a “buy” rating and issued a $8.00 price objective on shares of SBC Medical Group in a report on Thursday, August 13th. Weiss Ratings upgraded SBC Medical Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, October 9th. Finally, Wall Street Zen raised SBC Medical Group from a “buy” rating to a “strong-buy” rating in a report on Monday, October 5th. One equities research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, SBC Medical Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $8.00.

About SBC Medical Group

SBC Medical Group Holdings provides management and support services to medical institutions, with a focus on clinics offering aesthetic medicine. Its services include support for clinic operations, marketing, staff training, procurement and customer service, allowing affiliated medical providers to focus on patient care. The group is associated with the Shonan Beauty Clinic brand and a broader network of clinics offering services such as cosmetic surgery and dermatology. Its business is centered primarily in Japan, where it supports the operations and growth of affiliated medical institutions.